Salani, Jumarija A.
HRN: 16-48-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
METRONIDAZOLE 500MG (TAB)
06/07/2024
06/13/2024
PO
1 Tab
TID
Amoebiasis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes